B cells inhibit the antitumor immunity against an established urine fibrosarcoma [Separata] /

Despite the classic role of B cells in favoring the immune response, an inhibitory action of B lymphocytes in tumor immunity has emerged in certain studies. In methyl colanthrene‐induced murine fibrosarcoma (MCC), the loss of immunogenicity and the establishment of tolerance are paralleled by system...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autor principal: Maglioco, Andrea
Otros Autores: Machuca, Damian G., Badano, María Noel, Nannini, Paula, Camerano, Gabriela V., Costa, Héctor, Meiss, Roberto, Ruggiero, Raúl A., Giordano, Mirta, Dran, Graciela I.
Formato: Capítulo de libro
Lenguaje:Inglés
Materias:
Aporte de:Registro referencial: Solicitar el recurso aquí
LEADER 02869naa a2200361 a 4500
003 AR-BaFLA
008 191113t2016 gr d|||fs|||| 00| 0 eng d
999 |c 46714  |d 46714 
037 |n Depósito reglamentario 
040 |a FLACSO Argentina  |c FLACSO Argentina 
041 0 |a eng 
100 1 |9 33509  |a Maglioco, Andrea 
245 1 0 |a B cells inhibit the antitumor immunity against an established urine fibrosarcoma [Separata] /   |c Andrea Maglioco ...[y otros]  |h DIG 
300 |a pp. 1-8  |b diagrs. 
336 |2 rdacontent  |a Texto  |b txt 
337 |2 rdamedia  |a computadora  |b c 
338 |2 rdacarrier  |a Recurso el línea  |b cr 
504 |a incl. ref. 
520 |a Despite the classic role of B cells in favoring the immune response, an inhibitory action of B lymphocytes in tumor immunity has emerged in certain studies. In methyl colanthrene‐induced murine fibrosarcoma (MCC), the loss of immunogenicity and the establishment of tolerance are paralleled by systemic immune suppression and the appearance of B+ IL‐10+ cells in tumor‐draining lymph nodes. The present study aimed to assess the role of the B+ IL‐10+ cell population in the immune evasion and tolerance induced by MCC through the depletion of B cells in mice at various times of tumor progression: Prior to or subsequent to tumor implantation. Tumor growth and immunological parameters were evaluated. B cell depletion prior to tumor inoculum enhanced systemic immune response; however, an increase in the T regulatory cells (Tregs) at the tumor‐draining lymph node could account for tumor exacerbation. B cell depletion once the tumor was established resulted in decreased tumor growth and a delayed onset of tolerance. Additionally, B cell absence exacerbated T cell dependent‐tumor rejection, reduced Tregs and increased cytotoxic CD8+ T cells. In vitro analysis showed a direct effect of B cells upon T cell proliferation. In conclusion, B cell depletion exerts opposite effects when performed prior to or subsequent to tumor implantation. In this initially immunogenic tumor, B cell absence would delay the establishment of immunological tolerance probably by unmasking a pre‐existing antitumor response. The present findings elucidate the convenience of modulating B cells in the development of future and more effective immunotherapies against cancer. 
650 4 |9 2776  |a  INVESTIGACION MEDICA 
650 4 |9 5723  |a CANCER 
690 |a SALUD 
700 1 |9 33510  |a Machuca, Damian G. 
700 1 |9 33511  |a Badano, María Noel 
700 1 |9 33512  |a Nannini, Paula 
700 1 |9 33513  |a Camerano, Gabriela V. 
700 1 |9 33514  |a Costa, Héctor 
700 1 |9 33515  |a Meiss, Roberto 
700 1 |9 33516  |a Ruggiero, Raúl A. 
700 1 |9 33517  |a Giordano, Mirta 
700 1 |9 33518  |a Dran, Graciela I. 
773 0 |d Athens : Spandidos Publications, 2016  |t Oncology letters  |x 1792-1082 
942 |c ART